Nag, Nupur <br/><br/>
Assessing the efficacy of specific cerebellomodulatory drugs for use as therapy for spinocerebellar ataxia type 1.  [electronic resource] 

 -  Cerebellum (London, England)  Feb 2013 
 - 74-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4230 
<br/><br/><label>Standard No.: </label>10.1007/s12311-012-0399-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amantadine--pharmacology<br/>Animals<br/>Ataxin-1<br/>Ataxins<br/>Buspirone--pharmacology<br/>Disease Models, Animal<br/>Dopamine Agents--pharmacology<br/>Genotype<br/>Hypnotics and Sedatives--pharmacology<br/>Kyphosis--genetics<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Transgenic<br/>Motor Activity--drug effects<br/>Nerve Tissue Proteins--genetics<br/>Neuroprotective Agents--pharmacology<br/>Nuclear Proteins--genetics<br/>Phenotype<br/>Purkinje Cells--drug effects<br/>Pyridines--pharmacology<br/>Riluzole--pharmacology<br/>Serotonin Receptor Agonists--pharmacology<br/>Spinocerebellar Ataxias--drug therapy<br/>Zolpidem